540 related articles for article (PubMed ID: 33561212)
1. The role of radiotherapy in the age of immunotherapy.
Sato H; Demaria S; Ohno T
Jpn J Clin Oncol; 2021 Apr; 51(4):513-522. PubMed ID: 33561212
[TBL] [Abstract][Full Text] [Related]
2. Immune-priming of the tumor microenvironment by radiotherapy: rationale for combination with immunotherapy to improve anticancer efficacy.
Shahabi V; Postow MA; Tuck D; Wolchok JD
Am J Clin Oncol; 2015 Feb; 38(1):90-7. PubMed ID: 25616204
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity.
Donlon NE; Power R; Hayes C; Reynolds JV; Lysaght J
Cancer Lett; 2021 Apr; 502():84-96. PubMed ID: 33450360
[TBL] [Abstract][Full Text] [Related]
4. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.
Esposito A; Criscitiello C; Curigliano G
Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy and immunotherapy: a beneficial liaison?
Weichselbaum RR; Liang H; Deng L; Fu YX
Nat Rev Clin Oncol; 2017 Jun; 14(6):365-379. PubMed ID: 28094262
[TBL] [Abstract][Full Text] [Related]
6. The synergistic effect of radiotherapy and immunotherapy: A promising but not simple partnership.
Chajon E; Castelli J; Marsiglia H; De Crevoisier R
Crit Rev Oncol Hematol; 2017 Mar; 111():124-132. PubMed ID: 28259287
[TBL] [Abstract][Full Text] [Related]
7. The Reciprocity between Radiotherapy and Cancer Immunotherapy.
Wang Y; Liu ZG; Yuan H; Deng W; Li J; Huang Y; Kim BYS; Story MD; Jiang W
Clin Cancer Res; 2019 Mar; 25(6):1709-1717. PubMed ID: 30413527
[TBL] [Abstract][Full Text] [Related]
8. Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors.
Qi J; Jin F; Xu X; Du Y
Int J Nanomedicine; 2021; 16():1435-1456. PubMed ID: 33654395
[TBL] [Abstract][Full Text] [Related]
9. Rationale and evidence to combine radiation therapy and immunotherapy for cancer treatment.
Ishihara D; Pop L; Takeshima T; Iyengar P; Hannan R
Cancer Immunol Immunother; 2017 Mar; 66(3):281-298. PubMed ID: 27743027
[TBL] [Abstract][Full Text] [Related]
10. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.
Thomas R; Al-Khadairi G; Roelands J; Hendrickx W; Dermime S; Bedognetti D; Decock J
Front Immunol; 2018; 9():947. PubMed ID: 29770138
[TBL] [Abstract][Full Text] [Related]
11. Combination of radiotherapy and immune checkpoint inhibitors.
Pilones KA; Vanpouille-Box C; Demaria S
Semin Radiat Oncol; 2015 Jan; 25(1):28-33. PubMed ID: 25481263
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy and radiation.
Hiniker SM; Knox SJ
Semin Oncol; 2014 Dec; 41(6):702-13. PubMed ID: 25499631
[TBL] [Abstract][Full Text] [Related]
13. Adapting conventional cancer treatment for immunotherapy.
Qiao J; Liu Z; Fu YX
J Mol Med (Berl); 2016 May; 94(5):489-95. PubMed ID: 26910191
[TBL] [Abstract][Full Text] [Related]
14. Immune targets in the tumor microenvironment treated by radiotherapy.
Ozpiskin OM; Zhang L; Li JJ
Theranostics; 2019; 9(5):1215-1231. PubMed ID: 30867826
[TBL] [Abstract][Full Text] [Related]
15. Editorial to Radiation in Multimodal Tumor Immune Therapies-Mechanisms and Application.
Frey B; Gaipl US
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299268
[TBL] [Abstract][Full Text] [Related]
16. Immunologically augmented cancer treatment using modern radiotherapy.
Durante M; Reppingen N; Held KD
Trends Mol Med; 2013 Sep; 19(9):565-82. PubMed ID: 23831337
[TBL] [Abstract][Full Text] [Related]
17. Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations.
Colton M; Cheadle EJ; Honeychurch J; Illidge TM
Radiat Oncol; 2020 Nov; 15(1):254. PubMed ID: 33148287
[TBL] [Abstract][Full Text] [Related]
18. Tackling Resistance to Cancer Immunotherapy: What Do We Know?
Gondhowiardjo SA; Handoko ; Jayalie VF; Apriantoni R; Barata AR; Senoaji F; Utami IJW; Maubere F; Nuryadi E; Giselvania A
Molecules; 2020 Sep; 25(18):. PubMed ID: 32911646
[TBL] [Abstract][Full Text] [Related]
19. Combining immunotherapy and radiotherapy in head and neck squamous cell cancers: which perspectives?
Biau J; Bourhis J
Curr Opin Oncol; 2020 May; 32(3):196-202. PubMed ID: 32251158
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy and Immunotherapy: Improving Cancer Treatment through Synergy.
Reynders K; De Ruysscher D
Prog Tumor Res; 2015; 42():67-78. PubMed ID: 26383848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
